Ethnic disparities in clinical trials for FDA-approved drugs in urothelial cancer: An analysis in the post-COVID-19 era (2020-2024). Other Scholarly Work

Bastos, Bruno R, Schwartz, Michael A, Gligich, Oleg et al. (2025). Ethnic disparities in clinical trials for FDA-approved drugs in urothelial cancer: An analysis in the post-COVID-19 era (2020-2024). . JOURNAL OF CLINICAL ONCOLOGY, 43(5_SUPPL), 10.1200/JCO.2025.43.5_suppl.677

cited authors

  • Bastos, Bruno R; Schwartz, Michael A; Gligich, Oleg; Bhandari, Akshay; Kuritzky, Nicolas; Borregales, Leonardo; Barrientos, Jacqueline Claudia; Nieder, Alan; Linzer, Debra; Ramirez-Ridelli, Antonio; Cusnir, Mike

authors

publication date

  • February 10, 2025

published in

keywords

  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Location

  • CA, San Francisco

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

volume

  • 43

issue

  • 5_SUPPL